Literature DB >> 18408164

Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane.

Maarten F M Engel1, Lucie Khemtémourian, Cécile C Kleijer, Hans J D Meeldijk, Jet Jacobs, Arie J Verkleij, Ben de Kruijff, J Antoinette Killian, Jo W M Höppener.   

Abstract

Fibrillar protein deposits (amyloid) in the pancreatic islets of Langerhans are thought to be involved in death of the insulin-producing islet beta cells in type 2 diabetes mellitus. It has been suggested that the mechanism of this beta cell death involves membrane disruption by human islet amyloid polypeptide (hIAPP), the major constituent of islet amyloid. However, the molecular mechanism of hIAPP-induced membrane disruption is not known. Here, we propose a hypothesis that growth of hIAPP fibrils at the membrane causes membrane damage. We studied the kinetics of hIAPP-induced membrane damage in relation to hIAPP fibril growth and found that the kinetic profile of hIAPP-induced membrane damage is characterized by a lag phase and a sigmoidal transition, which matches the kinetic profile of hIAPP fibril growth. The observation that seeding accelerates membrane damage supports the hypothesis. In addition, variables that are well known to affect hIAPP fibril formation, i.e., the presence of a fibril formation inhibitor, hIAPP concentration, and lipid composition, were found to have the same effect on hIAPP-induced membrane damage. Furthermore, electron microscopy analysis showed that hIAPP fibrils line the surface of distorted phospholipid vesicles, in agreement with the notion that hIAPP fibril growth at the membrane and membrane damage are physically connected. Together, these observations point toward a mechanism in which growth of hIAPP fibrils, rather than a particular hIAPP species, is responsible for the observed membrane damage. This hypothesis provides an additional mechanism next to the previously proposed role of oligomers as the main cytotoxic species of amyloidogenic proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408164      PMCID: PMC2329711          DOI: 10.1073/pnas.0708354105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Quantification of beta-sheet amyloid fibril structures with thioflavin T.

Authors:  H LeVine
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  Mechanisms of amyloidogenesis.

Authors:  J W Kelly
Journal:  Nat Struct Biol       Date:  2000-10

3.  Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases.

Authors:  Rakez Kayed; Yuri Sokolov; Brian Edmonds; Theresa M McIntire; Saskia C Milton; James E Hall; Charles G Glabe
Journal:  J Biol Chem       Date:  2004-09-21       Impact factor: 5.157

4.  Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity.

Authors:  J McLaurin; A Chakrabartty
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

5.  A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation.

Authors:  Y C Kudva; C Mueske; P C Butler; N L Eberhardt
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

6.  Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells.

Authors:  H J Hiddinga; N L Eberhardt
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

Review 7.  Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.

Authors:  J D Harper; P T Lansbury
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

8.  The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.

Authors:  J Janson; R H Ashley; D Harrison; S McIntyre; P C Butler
Journal:  Diabetes       Date:  1999-03       Impact factor: 9.461

9.  Effects of beta cell granule components on human islet amyloid polypeptide fibril formation.

Authors:  P Westermark; Z C Li; G T Westermark; A Leckström; D F Steiner
Journal:  FEBS Lett       Date:  1996-02-05       Impact factor: 4.124

10.  Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis.

Authors:  T D O'Brien; P C Butler; D K Kreutter; L A Kane; N L Eberhardt
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

View more
  155 in total

1.  Atomic view of a toxic amyloid small oligomer.

Authors:  Arthur Laganowsky; Cong Liu; Michael R Sawaya; Julian P Whitelegge; Jiyong Park; Minglei Zhao; Anna Pensalfini; Angela B Soriaga; Meytal Landau; Poh K Teng; Duilio Cascio; Charles Glabe; David Eisenberg
Journal:  Science       Date:  2012-03-09       Impact factor: 47.728

2.  How type II diabetes-related islet amyloid polypeptide damages lipid bilayers.

Authors:  Chang-Chun Lee; Yen Sun; Huey W Huang
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

3.  Effect of sequence variation on the mechanical response of amyloid fibrils probed by steered molecular dynamics simulation.

Authors:  Hlengisizwe Ndlovu; Alison E Ashcroft; Sheena E Radford; Sarah A Harris
Journal:  Biophys J       Date:  2012-02-07       Impact factor: 4.033

4.  Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.

Authors:  Jeffrey R Brender; Samer Salamekh; Ayyalusamy Ramamoorthy
Journal:  Acc Chem Res       Date:  2011-09-25       Impact factor: 22.384

5.  A yeast toxic mutant of HET-s((218-289)) prion displays alternative intermediates of amyloidogenesis.

Authors:  Karine Berthelot; Sophie Lecomte; Julie Géan; Françoise Immel; Christophe Cullin
Journal:  Biophys J       Date:  2010-08-09       Impact factor: 4.033

6.  Deletion of Fas protects islet beta cells from cytotoxic effects of human islet amyloid polypeptide.

Authors:  Y J Park; S Lee; T J Kieffer; G L Warnock; N Safikhan; M Speck; Z Hao; M Woo; L Marzban
Journal:  Diabetologia       Date:  2012-02-01       Impact factor: 10.122

7.  A Kinetic Model for Cell Damage Caused by Oligomer Formation.

Authors:  Liu Hong; Ya-Jing Huang; Wen-An Yong
Journal:  Biophys J       Date:  2015-10-06       Impact factor: 4.033

Review 8.  Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.

Authors:  Ping Cao; Peter Marek; Harris Noor; Vadim Patsalo; Ling-Hsien Tu; Hui Wang; Andisheh Abedini; Daniel P Raleigh
Journal:  FEBS Lett       Date:  2013-02-01       Impact factor: 4.124

9.  Islet amyloid polypeptide toxicity and membrane interactions.

Authors:  Ping Cao; Andisheh Abedini; Hui Wang; Ling-Hsien Tu; Xiaoxue Zhang; Ann Marie Schmidt; Daniel P Raleigh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

10.  Membrane disordering is not sufficient for membrane permeabilization by islet amyloid polypeptide: studies of IAPP(20-29) fragments.

Authors:  Jeffrey R Brender; Deborah L Heyl; Shyamprasad Samisetti; Samuel A Kotler; Joshua M Osborne; Ranadheer R Pesaru; Ayyalusamy Ramamoorthy
Journal:  Phys Chem Chem Phys       Date:  2013-03-15       Impact factor: 3.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.